https://doctransparency.com/doctor/fl/tampa/steven-maskin-1124174479
Medicare Enrolled

Dr. Steven Maskin, M.D.

Ophthalmology · Tampa, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Mixed engagement
3001 W SWANN AVE, Tampa, FL 33609
8138750000
In practice since 2007 (19 years)
NPI: 1124174479 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Maskin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Maskin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Maskin

Dr. Steven Maskin is an ophthalmology in Tampa, FL, with 19 years in practice. Based on federal Medicare data, Dr. Maskin performed 707 Medicare services across 227 unique beneficiaries.

Between the years covered by Open Payments, Dr. Maskin received a total of $70,986 from 12 pharmaceutical and/or device companies across 39 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are classified as financial or ownership interests (royalties, licensing fees, or investment interests). Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Maskin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 707 Medicare services$ $70,986 industry payments

Medicare Practice Summary

Medicare Utilization ↗
707
Medicare services
Bottom 22% in FL for ophthalmology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
227
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~37 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Eye exam, established patient, focused318$63$250
Incision and drainage of abscess of eyelid190$178$1,000
Fitting of contact lens for treatment of eye surface disease126$27$165
Repair tear duct opening by heat, tying, or laser surgery50$123$826
New patient office visit (45-59 min)23$107$415
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.1% high complexity
0.0% medium
92.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$70,986
Total received (2018-2024)
Avg $10,141/year across 7 years
Top 6% in FL for ophthalmology
12
Companies
39
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$41,938 (59.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$28,752 (40.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$296 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$10,302
2023
$12,137
2022
$10,282
2021
$10,254
2020
$9,407
2019
$11,396
2018
$7,209

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Katena Products, Inc.
$60,405
Surgical Specialties Corporation (us), Inc. (dba Corza Medical)
$10,285
Mallinckrodt Hospital Products Inc.
$93
Oyster Point Pharma, Inc.
$37
Ethicon US, LLC
$27
SUN PHARMACEUTICAL INDUSTRIES INC.
$25
Kala Pharmaceuticals, Inc.
$25
Baxter Healthcare
$23
Allergan, Inc.
$21
Bausch & Lomb Americas Inc.
$17
Alcon Vision LLC
$16
Integra LifeSciences Corporation
$13
Top 3 companies account for 99.7% of total payments
Associated products mentioned in payments ›
ACTHAR · BIOFIX · Cequa · INVELTYS · Surgical instrument · Systane Complete · TISSEEL · TYRVAYA · VISTASEAL · VUITY · VYZULTA · katena
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 6% for ophthalmology in FL.

Equivalent to $10,040 per 100 Medicare services performed
Looking for a ophthalmology in Tampa?
Compare ophthalmologys in the Tampa area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologys nearby

Geographic Context

Ophthalmologys within 10 mi
195
Per 100K population
13.1
County median income
$75,011
Nearest hospital
HCA FLORIDA SOUTH TAMPA HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Maskin is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (mixed engagement, top 6%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Maskin experienced with eye exam, established patient, focused?
Based on Medicare claims data, Dr. Maskin performed 318 eye exam, established patient, focused services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Maskin receive payments from pharmaceutical companies?
Yes. Dr. Maskin received a total of $70,986 from 12 companies across 39 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Maskin's costs compare to other ophthalmologys in Tampa?
Dr. Maskin's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Maskin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →